SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-068565
Filing Date
2017-11-14
Accepted
2017-11-14 17:21:02
Documents
86
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-20668_110q.htm 10-Q 1639445
2 EX-31.1 a17-20668_1ex31d1.htm EX-31.1 11076
3 EX-31.2 a17-20668_1ex31d2.htm EX-31.2 11075
4 EX-32.1 a17-20668_1ex32d1.htm EX-32.1 7826
  Complete submission text file 0001104659-17-068565.txt   8152355

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bhvn-20170930.xml EX-101.INS 1443540
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20170930.xsd EX-101.SCH 75395
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20170930_cal.xml EX-101.CAL 46485
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bhvn-20170930_lab.xml EX-101.LAB 643764
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20170930_pre.xml EX-101.PRE 628413
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20170930_def.xml EX-101.DEF 405211
Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 171203040
SIC: 2834 Pharmaceutical Preparations